ALX Oncology Holdings Inc.

ALXO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$135-$161-$123-$83
Dep. & Amort.$1$1$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$27$26$24$14
Change in WC-$12$8$10-$4
Other Non-Cash-$3-$5$0$5
Operating Cash Flow-$122-$130-$89-$68
Investing Activities
PP&E Inv.-$0-$1-$1-$5
Net Acquisitions$0$0$0$0
Inv. Purchases-$107-$247-$377$0
Inv. Sales/Matur.$194$293$143$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow$86$45-$235-$5
Financing Activities
Debt Repay.-$1-$0$10-$0
Stock Issued$32$59$1$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1-$1$0
Financing Cash Flow$31$59$10$2
Forex Effect$0$0$0$0
Net Chg. in Cash-$5-$26-$315-$71
Supplemental Information
Beg. Cash$22$49$364$434
End Cash$18$22$49$364
Free Cash Flow-$122-$132-$91-$73
ALX Oncology Holdings Inc. (ALXO) Financial Statements & Key Stats | AlphaPilot